Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Change in Inventory: 2020-2024

Historic Change in Inventory for Journey Medical (DERM) over the last 5 years, with Dec 2024 value amounting to $4.2 million.

  • Journey Medical's Change in Inventory fell 149.21% to -$1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30,000, marking a year-over-year decrease of 96.07%. This contributed to the annual value of $4.2 million for FY2024, which is 206.88% up from last year.
  • As of FY2024, Journey Medical's Change in Inventory stood at $4.2 million, which was up 206.88% from -$4.0 million recorded in FY2023.
  • Over the past 5 years, Journey Medical's Change in Inventory peaked at $8.5 million during FY2021, and registered a low of -$4.0 million during FY2023.
  • In the last 3 years, Journey Medical's Change in Inventory had a median value of -$1.7 million in 2022 and averaged -$490,667.
  • Per our database at Business Quant, Journey Medical's Change in Inventory skyrocketed by 1,446.25% in 2021 and then tumbled by 126.66% in 2023.
  • Over the past 5 years, Journey Medical's Change in Inventory (MRY) stood at $547,000 in 2020, then skyrocketed by 1,446.25% to $8.5 million in 2021, then tumbled by 120.62% to -$1.7 million in 2022, then tumbled by 126.66% to -$4.0 million in 2023, then surged by 206.88% to $4.2 million in 2024.
  • Its Change in Inventory stands at $4.2 million for FY2024, versus -$4.0 million for FY2023 and -$1.7 million for FY2022.